Skip to content

Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer

Impact of Dedicated Breast Positron Emission Mammography vs. Conventional Two-View Digital Mammography on Recall Rates and Cancer Detection as a Screening Examination in Underserved Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00896649
Enrollment
193
Registered
2009-05-12
Start date
2009-02-28
Completion date
2017-01-31
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer

Brief summary

RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective than standard mammography in finding breast tumors. PURPOSE: This phase III trial is studying positron emission mammography to see how well it works compared with standard mammography in women undergoing screening mammogram at Boston Medical Center.

Detailed description

OBJECTIVES: * To install the breast Positron Emission Mammography system and to test and ensure its compliance with all regulatory agencies including the American College of Radiology and the Food and Drug Administration. * To measure and compare the number of call-backs for positron emission mammography (PEM) imaging and conventional mammography. * To measure and compare patient satisfaction for both conventional mammography and positron emission mammography in terms of comfort and pain. OUTLINE: Patients undergo a conventional two-view mammogram and positron emission mammography (PEM). Immediately following treatment, patients complete a questionnaire on their satisfaction with the standard mammogram and the positron emission mammography. After completion of study treatment, patients are followed annually.

Interventions

OTHERquestionnaire administration

Questionnaire regarding patient satisfaction with mammogram experience and with positron emission mammography experience.

standard screening mammogram

one-time positron emission mammography to compare recall rates with that of standard mammogram

Sponsors

United States Department of Defense
CollaboratorFED
Boston Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

PEM

Eligibility

Sex/Gender
FEMALE
Age
35 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

DISEASE CHARACTERISTICS: * Scheduled to undergo screening mammogram at one of the Boston Medical Center-affiliated primary care clinics and meets 1 of the following criteria: * Dense breast tissue * At high-risk for breast cancer PATIENT CHARACTERISTICS: * Has 1 of the following racial or ethnic backgrounds based on the patient's country of birth or the mother and father's country of birth: * Hispanic * Haitian Creole * African American * Caucasian PRIOR CONCURRENT THERAPY: * None specified

Exclusion criteria

* No history of breast cancer, palpable breast mass, abnormal nipple discharge, or other focal complaints warranting diagnostic mammogram

Design outcomes

Primary

MeasureTime frameDescription
Frequency of Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 Call-back in Mammography vs Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 in Positron Emission Mammographyimmediately at completion of mammogramNumber of participants called back due to Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 Mammogram compared to number of patients with Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 in positron emission mammography Breast Imaging Assessment Reporting and Data System (BI-RADS) Scale: 0 = Inconclusive for malignancy; call-back in mammography 1. = normal 2. = abnormal, with no malignancy 3. = abnormal, likely benign 4. = abnormal, likely malignant 5. = malignant

Secondary

MeasureTime frameDescription
Patient Satisfaction Level as Pertaining to Comfort and Pain for Each StudyOne monthNumber of participants satisfied with positron emission mammography with regard to comfort and pain for each study 1-7 rating scale, Entries from 1-4 considered Satisfied. Entries 5-7 considered not Satisfied.

Countries

United States

Participant flow

Recruitment details

193 participants were enrolled onto this study between 4/8/2009 through 5/31/2012 in the Breast Center.

Participants by arm

ArmCount
Positron Emission Mammography (PEM), Mammography, Questionaire
questionnaire administration digital mammography positron emission mammography questionnaire administration: Questionnaire regarding patient satisfaction with mammogram experience and with positron emission mammography experience. digital mammography: standard screening mammogram positron emission mammography: one-time positron emission mammography to compare recall rates with that of standard mammogram
193
Total193

Withdrawals & dropouts

PeriodReasonFG000
Overall Studymissing documentation1
Overall StudyPhysician Decision1
Overall StudyPregnancy1
Overall Studytechnical difficulties2

Baseline characteristics

CharacteristicPositron Emission Mammography (PEM), Mammography, Questionaire
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
182 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
185 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
No prior history of cancer in previous 5 years193 participants
Pregnancy status
negative pregnancy status
192 Participants
Pregnancy status
pregnant status
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
113 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
80 Participants
Region of Enrollment
United States
193 Participants
Sex/Gender, Customized
Female
193 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 188
serious
Total, serious adverse events
0 / 188

Outcome results

Primary

Frequency of Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 Call-back in Mammography vs Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 in Positron Emission Mammography

Number of participants called back due to Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 Mammogram compared to number of patients with Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 in positron emission mammography Breast Imaging Assessment Reporting and Data System (BI-RADS) Scale: 0 = Inconclusive for malignancy; call-back in mammography 1. = normal 2. = abnormal, with no malignancy 3. = abnormal, likely benign 4. = abnormal, likely malignant 5. = malignant

Time frame: immediately at completion of mammogram

Population: Number of participants who completed protocol with complete data set

ArmMeasureGroupValue (NUMBER)
Single Arm Positron Emission Mammography and QuestionnaireFrequency of Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 Call-back in Mammography vs Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 in Positron Emission MammographyNumber of BI-RAD 0 Mammogram28 participants
Single Arm Positron Emission Mammography and QuestionnaireFrequency of Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 Call-back in Mammography vs Breast Imaging Assessment Reporting and Data System (BI-RADS) 0 in Positron Emission MammographyNumber of BI-RAD 0 positron emission mammograph27 participants
Secondary

Patient Satisfaction Level as Pertaining to Comfort and Pain for Each Study

Number of participants satisfied with positron emission mammography with regard to comfort and pain for each study 1-7 rating scale, Entries from 1-4 considered Satisfied. Entries 5-7 considered not Satisfied.

Time frame: One month

Population: All participants who completed imaging and questionnaires.

ArmMeasureGroupValue (NUMBER)
Single Arm Positron Emission Mammography and QuestionnairePatient Satisfaction Level as Pertaining to Comfort and Pain for Each StudySatisfied With Experience: Mammogram165 participants
Single Arm Positron Emission Mammography and QuestionnairePatient Satisfaction Level as Pertaining to Comfort and Pain for Each StudyNot Satisifed with Experience: Mammogram23 participants
Single Arm Positron Emission Mammography and QuestionnairePatient Satisfaction Level as Pertaining to Comfort and Pain for Each StudySatisfied with the Experience: PEM175 participants
Single Arm Positron Emission Mammography and QuestionnairePatient Satisfaction Level as Pertaining to Comfort and Pain for Each StudyNot Satisfied with the Experience: PEM13 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026